Literature DB >> 25730722

Life after diagnosis and treatment of cancer in adulthood: contributions from psychosocial oncology research.

Annette L Stanton1, Julia H Rowland2, Patricia A Ganz3.   

Abstract

The number of individuals living with a history of cancer is estimated at 13.7 million in the United States and is expected to rise with the aging of the population. With expanding attention to the psychosocial and physical consequences of surviving illness, psychological science and evidence-based practice are making important contributions to addressing the pressing needs of cancer survivors. Research is demonstrating that adults diagnosed with cancer evidence generally positive psychosocial adjustment over time; however, a subset is at risk for compromised psychological and physical health stemming from long-term or late effects of cancer and its treatment. In this article, we characterize survivorship after medical treatment completion during the periods of reentry, early survivorship, and long-term survivorship. We describe the major psychosocial and physical sequelae facing adults during those periods, highlight promising posttreatment psychosocial and behavioral interventions, and offer recommendations for future research and evidence-based practice. PsycINFO Database Record (c) 2015 APA, all rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25730722     DOI: 10.1037/a0037875

Source DB:  PubMed          Journal:  Am Psychol        ISSN: 0003-066X


  58 in total

1.  Initial evaluation of the validity and reliability of the culturally adapted Spanish CaSUN (S-CaSUN).

Authors:  Dinorah Martinez Tyson; Patricia Medina-Ramirez; Coralia Vázquez-Otero; Clement K Gwede; Margarita Bobonis Babilonia; Susan C McMillan
Journal:  J Cancer Surviv       Date:  2018-04-05       Impact factor: 4.442

Review 2.  Provision of integrated psychosocial services for cancer survivors post-treatment.

Authors:  Christopher J Recklitis; Karen L Syrjala
Journal:  Lancet Oncol       Date:  2017-01       Impact factor: 41.316

Review 3.  Post-traumatic stress disorder and cancer.

Authors:  Matthew J Cordova; Michelle B Riba; David Spiegel
Journal:  Lancet Psychiatry       Date:  2017-01-19       Impact factor: 27.083

4.  Trajectories of Stress, Depressive Symptoms, and Immunity in Cancer Survivors: Diagnosis to 5 Years.

Authors:  Barbara L Andersen; Neha Godiwala Goyal; Travis D Westbrook; Brenden Bishop; William E Carson
Journal:  Clin Cancer Res       Date:  2016-07-12       Impact factor: 12.531

5.  Representations of cancer recurrence risk, recurrence worry, and health-protective behaviours: an elaborated, systematic review.

Authors:  Arturo Durazo; Linda D Cameron
Journal:  Health Psychol Rev       Date:  2019-06-03

6.  Physical Activity in Older Cancer Survivors: What Role Do Multimorbidity and Perceived Disability Play?

Authors:  Shirley M Bluethmann; Wayne Foo; Renate M Winkels; Scherezade K Mama; Kathryn H Schmitz
Journal:  J Aging Phys Act       Date:  2020-04-24       Impact factor: 1.961

Review 7.  Cognitive behavioral therapy for cancer-related cognitive dysfunction.

Authors:  Shelly Kucherer; Robert J Ferguson
Journal:  Curr Opin Support Palliat Care       Date:  2017-03       Impact factor: 2.302

8.  Differences in Health-Related Quality of Life and Health Behaviors Among Lesbian, Bisexual, and Heterosexual Women Surviving Cancer from the 2013 to 2018 National Health Interview Survey.

Authors:  Megan L Hutchcraft; Andreas A Teferra; Lauren Montemorano; Joanne G Patterson
Journal:  LGBT Health       Date:  2020-12-16       Impact factor: 4.151

9.  Long-Term Survivorship Care After Cancer Treatment - Summary of a 2017 National Cancer Policy Forum Workshop.

Authors:  Ronald M Kline; Neeraj K Arora; Cathy J Bradley; Eden R Brauer; Darci L Graves; Natasha Buchanan Lunsford; Mary S McCabe; Shelley Fuld Nasso; Larissa Nekhlyudov; Julia H Rowland; Rebekkah M Schear; Patricia A Ganz
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

10.  The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy.

Authors:  C Miaskowski; B A Cooper; B Aouizerat; M Melisko; L-M Chen; L Dunn; X Hu; K M Kober; J Mastick; J D Levine; M Hammer; F Wright; J Harris; J Armes; E Furlong; P Fox; E Ream; R Maguire; N Kearney
Journal:  Eur J Cancer Care (Engl)       Date:  2016-01-18       Impact factor: 2.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.